Celyad Oncology SA (NASDAQ:CYAD) Q4 2022 Earnings Call Transcript

Operator: Greetings. Welcome to the Celyad Oncology Full-Year 2022 Financial Results. At this time, all participants are in a listen-only mode.

Keep Reading →